Change Language

Select Language

Global Stem Cell Banking Market to Reach US$ 10.9 Billion by 2027, Spurred by Rising Prevalence of Chronic Diseases

Published on Jul 22, 2019

The latest report by IMARC Group, titled “Stem Cell Banking Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, estimates that the global stem cell banking market size reached US$ 6.8 Billion in 2021. Stem cell banking refers to the collection and preservation of stems cells to utilize them for future use. Placenta, umbilical cord, amniotic fluid, bone marrow and adipose tissue are a few of the common sources of stem cells. These cells can be frozen for decades and used to produce platelets, red blood cells (RBCs) and white blood cells (WBCs). A stem cell transplant takes place by injecting healthy stem cells to the damaged, diseased or malfunctioning cells or tissues present in the body. They are extensively used to treat various life-threatening diseases and genetic disorders including thalassemia, sickle cell anemia, leukemia, sarcoma, diabetes and lymphoma.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Stem Cell Banking Market Trends:

Owing to hectic lifestyles, changing dietary preferences and negligible physical activities, there has been a significant increase in the prevalence of chronic and lifestyle diseases across the globe. This, coupled with the growing geriatric population, is significantly contributing to the demand for stem cell banking. Apart from this, several organizations are taking initiatives to educate people about the benefits associated with this procedure and encouraging them to donate stem cells for future use. For instance, in the UK, the International Stem Cell Banking Initiative (ISCBI) is actively engaged in establishing an ethical framework for international stem cell banking and research while assisting the development of new banks across numerous countries. Inflating income levels and rising fertility rates are some of the other factors that are providing a thrust to the market growth. On account of the aforementioned factors, the market is expected to reach a value of US$ 10.9 Billion by 2027, expanding at a CAGR of 8.42% during 2022-2027.

Market Summary:

  • Based on the product type, the market has been divided into adult stem cells, human embryonic cells and induced pluripotent stem (IPS) cells. Amongst these, adult stem cells represent the leading segment.
  • On the basis of the service type, the market has been categorized into sample preservation and storage; sample analysis; sample processing; and sample collection and transportation, wherein sample preservation and storage exhibits a clear dominance in the market.
  • Based on the bank type, the market has been bifurcated into private and public stem cell banks, wherein private stem cell banks account for the majority of the total market share.
  • On the basis of the utilization, the market has been classified into used and unused.
  • Based on the application, the market has been segregated into personalized banking, research and clinical applications. At present, clinical applications represent the largest market segment.
  • On the geographical front, North America exhibits a clear dominance in the market. Other regions include Europe, Asia Pacific, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been analyzed with the detailed profiles of the key players. Some of the leading players operating in the market include CBR Systems Inc., China Cord Blood Corporation, Cordlife, Cordvida, Cryo-Cell International, Inc., Cryo-Save AG (A Group of Esperite), Cryoviva India, Lifecell, Smart Cells International Ltd. and Viacord.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

USA: +1-631-791-1145
Follow us on twitter : @imarcglobal


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at